THBD and Sepsis: In our previous study reporting the protective effect of recombinant human thrombomodulin (rhTM) in a preterm sepsis mouse model, five LMs were significantly suppressed in the rhTM-treated pups 3 h post-sepsis induction, and an improved survival rate was observed [22].